Copyright Reports & Markets. All rights reserved.

Global Pravastatin Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Pravastatin

      • 1.1 Definition of Pravastatin
      • 1.2 Pravastatin Segment by Type
        • 1.2.1 Global Pravastatin Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 10mg tablet
        • 1.2.3 20mg tablet
        • 1.2.4 40mg tablet
        • 1.2.5 80mg tablet
      • 1.3 Pravastatin Segment by Applications
        • 1.3.1 Global Pravastatin Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Adults
        • 1.3.3 Children
      • 1.4 Global Pravastatin Overall Market
        • 1.4.1 Global Pravastatin Revenue (2014-2025)
        • 1.4.2 Global Pravastatin Production (2014-2025)
        • 1.4.3 North America Pravastatin Status and Prospect (2014-2025)
        • 1.4.4 Europe Pravastatin Status and Prospect (2014-2025)
        • 1.4.5 China Pravastatin Status and Prospect (2014-2025)
        • 1.4.6 Japan Pravastatin Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Pravastatin Status and Prospect (2014-2025)
        • 1.4.8 India Pravastatin Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Pravastatin
      • 2.3 Manufacturing Process Analysis of Pravastatin
      • 2.4 Industry Chain Structure of Pravastatin

      3 Development and Manufacturing Plants Analysis of Pravastatin

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Pravastatin Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Pravastatin
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Pravastatin Production and Capacity Analysis
      • 4.2 Pravastatin Revenue Analysis
      • 4.3 Pravastatin Price Analysis
      • 4.4 Market Concentration Degree

      5 Pravastatin Regional Market Analysis

      • 5.1 Pravastatin Production by Regions
        • 5.1.1 Global Pravastatin Production by Regions
        • 5.1.2 Global Pravastatin Revenue by Regions
      • 5.2 Pravastatin Consumption by Regions
      • 5.3 North America Pravastatin Market Analysis
        • 5.3.1 North America Pravastatin Production
        • 5.3.2 North America Pravastatin Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Pravastatin Import and Export
      • 5.4 Europe Pravastatin Market Analysis
        • 5.4.1 Europe Pravastatin Production
        • 5.4.2 Europe Pravastatin Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Pravastatin Import and Export
      • 5.5 China Pravastatin Market Analysis
        • 5.5.1 China Pravastatin Production
        • 5.5.2 China Pravastatin Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Pravastatin Import and Export
      • 5.6 Japan Pravastatin Market Analysis
        • 5.6.1 Japan Pravastatin Production
        • 5.6.2 Japan Pravastatin Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Pravastatin Import and Export
      • 5.7 Southeast Asia Pravastatin Market Analysis
        • 5.7.1 Southeast Asia Pravastatin Production
        • 5.7.2 Southeast Asia Pravastatin Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Pravastatin Import and Export
      • 5.8 India Pravastatin Market Analysis
        • 5.8.1 India Pravastatin Production
        • 5.8.2 India Pravastatin Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Pravastatin Import and Export

      6 Pravastatin Segment Market Analysis (by Type)

      • 6.1 Global Pravastatin Production by Type
      • 6.2 Global Pravastatin Revenue by Type
      • 6.3 Pravastatin Price by Type

      7 Pravastatin Segment Market Analysis (by Application)

      • 7.1 Global Pravastatin Consumption by Application
      • 7.2 Global Pravastatin Consumption Market Share by Application (2014-2019)

      8 Pravastatin Major Manufacturers Analysis

      • 8.1 Bristol-Myers Squibb
        • 8.1.1 Bristol-Myers Squibb Pravastatin Production Sites and Area Served
        • 8.1.2 Bristol-Myers Squibb Product Introduction, Application and Specification
        • 8.1.3 Bristol-Myers Squibb Pravastatin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 TEVA
        • 8.2.1 TEVA Pravastatin Production Sites and Area Served
        • 8.2.2 TEVA Product Introduction, Application and Specification
        • 8.2.3 TEVA Pravastatin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 SANDOZ
        • 8.3.1 SANDOZ Pravastatin Production Sites and Area Served
        • 8.3.2 SANDOZ Product Introduction, Application and Specification
        • 8.3.3 SANDOZ Pravastatin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 APOTEX
        • 8.4.1 APOTEX Pravastatin Production Sites and Area Served
        • 8.4.2 APOTEX Product Introduction, Application and Specification
        • 8.4.3 APOTEX Pravastatin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Dr. Reddy's Laboratories
        • 8.5.1 Dr. Reddy's Laboratories Pravastatin Production Sites and Area Served
        • 8.5.2 Dr. Reddy's Laboratories Product Introduction, Application and Specification
        • 8.5.3 Dr. Reddy's Laboratories Pravastatin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Zydus Pharmaceuticals
        • 8.6.1 Zydus Pharmaceuticals Pravastatin Production Sites and Area Served
        • 8.6.2 Zydus Pharmaceuticals Product Introduction, Application and Specification
        • 8.6.3 Zydus Pharmaceuticals Pravastatin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Cipla Inc.
        • 8.7.1 Cipla Inc. Pravastatin Production Sites and Area Served
        • 8.7.2 Cipla Inc. Product Introduction, Application and Specification
        • 8.7.3 Cipla Inc. Pravastatin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Lupin Pharmaceuticals
        • 8.8.1 Lupin Pharmaceuticals Pravastatin Production Sites and Area Served
        • 8.8.2 Lupin Pharmaceuticals Product Introduction, Application and Specification
        • 8.8.3 Lupin Pharmaceuticals Pravastatin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Glenmark
        • 8.9.1 Glenmark Pravastatin Production Sites and Area Served
        • 8.9.2 Glenmark Product Introduction, Application and Specification
        • 8.9.3 Glenmark Pravastatin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Mylan
        • 8.10.1 Mylan Pravastatin Production Sites and Area Served
        • 8.10.2 Mylan Product Introduction, Application and Specification
        • 8.10.3 Mylan Pravastatin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Aurobindo Pharma
      • 8.12 Accord Healthcare
      • 8.13 Upsher-Smith Laboratories
      • 8.14 Hisun
      • 8.15 Jiangxi Boyaseehot Pharmaceutical
      • 8.16 Shanghai Shyndec Pharmaceutical
      • 8.17 Daiichi Sankyo
      • 8.18 North China Pharmaceutical Group

      9 Development Trend of Analysis of Pravastatin Market

      • 9.1 Global Pravastatin Market Trend Analysis
        • 9.1.1 Global Pravastatin Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Pravastatin Regional Market Trend
        • 9.2.1 North America Pravastatin Forecast 2019-2025
        • 9.2.2 Europe Pravastatin Forecast 2019-2025
        • 9.2.3 China Pravastatin Forecast 2019-2025
        • 9.2.4 Japan Pravastatin Forecast 2019-2025
        • 9.2.5 Southeast Asia Pravastatin Forecast 2019-2025
        • 9.2.6 India Pravastatin Forecast 2019-2025
      • 9.3 Pravastatin Market Trend (Product Type)
      • 9.4 Pravastatin Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Pravastatin Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Pravastatin (marketed as Pravachol or Selektine) is a member of the drug class of statins, used in combination with diet, exercise, and weight loss for lowering cholesterol and preventing cardiovascular disease.

        The global Pravastatin market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Pravastatin volume and value at global level, regional level and company level. From a global perspective, this report represents overall Pravastatin market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Pravastatin in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Pravastatin manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Bristol-Myers Squibb
        TEVA
        SANDOZ
        APOTEX
        Dr. Reddy's Laboratories
        Zydus Pharmaceuticals
        Cipla Inc.
        Lupin Pharmaceuticals
        Glenmark
        Mylan
        Aurobindo Pharma
        Accord Healthcare
        Upsher-Smith Laboratories
        Hisun
        Jiangxi Boyaseehot Pharmaceutical
        Shanghai Shyndec Pharmaceutical
        Daiichi Sankyo
        North China Pharmaceutical Group

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        10mg tablet
        20mg tablet
        40mg tablet
        80mg tablet

        Segment by Application
        Adults
        Children

        Buy now